EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Isolation of Novel Fully Human Single-Domain Antibodies Targeting GUCY2C from a Heavy-Chain-Only Transgenic Mouse Platform

Pingxia Zhu iD, Lei He, Xiaoming Du, Pengsha Pang, Zhihua Ji, Yanyu Yang, Fengqi Cao, Quanjun Wang

Technology in Cancer Research & Treatment · 2026-08 · 25

DOI: 10.1177/15330338261473054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, online erschienen am 11.08.2026. Verfasst von Pingxia Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Antibody Discovery Department, SAFE Pharmaceutical Services Corp., Beijing, China. Hauptthemen laut MEDLINE: Single-Domain Antibodies, Immunoglobulin Heavy Chains. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: SAFE Pharmaceutical Services Corp.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Traditional natural single-domain antibodies(sdAbs) are primarily derived from camelids and sharks. However, the large size and slow reproduction of these species limit their widespread application in antibody development. In this study, we employed a fully human heavy-chain-only antibody mouse ( huNano mouse ) platform and a rapid, efficient preparation process to successfully develop fully human heavy-chain-only antibodies(HcAbs) targeting the tumor antigen guanylyl cyclase C (GC-C). These sdAbs provide high-quality candidate molecules for subsequent GC-C-based CAR-T therapy and bispecific antibody drug development.

Methods

Fully huNano mice were immunized with GC-C recombinant protein. SdAb sequences specifically binding to GC-C were selected via phage display technology and subsequently cloned into mammalian expression vectors for expression and purification. The binding activity, affinity, thermal stability, and monomeric dispersion of the antibodies were systematically evaluated using various methods, including ELISA, flow cytometry (FACS), biolayer interferometry (BLI), and size-exclusion chromatography (SEC-HPLC).

Results

Multiple sdAbs with specific recognition of GC-C were successfully obtained and exhibited strong binding affinities. After one-step purification, the monomeric purity of most antibodies exceeded 95%, with aggregate content below 5%. The nanobodies exhibited good thermal stability, with melting temperature (Tm) and aggregation onset temperature (Tagg) both falling within the range of 60–68 °C, demonstrating excellent drug development potential.

Conclusion

These results validate the capability of the huNano mouse platform to efficiently produce high-quality, fully human sdAbs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Domain AntibodiesImmunoglobulin Heavy ChainsAnimalsHumansMiceMice, TransgenicAntibody Affinity

Stichwörter der Autor:innen

GUCY2C (GC-C)fully human heavy-chain-only antibody mouse (HuNano mouse), nanobody(Nb)phage display technologysingle-domain antibody (sdAb); heavy-chain-only antibod(HcAb)

Substanzen

Single-Domain AntibodiesImmunoglobulin Heavy Chains

Autor:innen und Institutionen

  • Antibody Discovery Department, SAFE Pharmaceutical Services Corp., Beijing, China.
  • Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
  • Gene Editing Department, Beijing Life-Biosciences Corp., Beijing, China.

ORCID-Profile: Pingxia Zhu

Förderung

  • SAFE Pharmaceutical Services Corp

Zitieren

APA

Zhu, P., He, L., Du, X., Pang, P., Ji, Z., Yang, Y., Cao, F., & Wang, Q. (2026). Isolation of Novel Fully Human Single-Domain Antibodies Targeting GUCY2C from a Heavy-Chain-Only Transgenic Mouse Platform. Technology in Cancer Research & Treatment, 25. https://doi.org/10.1177/15330338261473054

Vancouver

Zhu P, He L, Du X, Pang P, Ji Z, Yang Y, et al. Isolation of Novel Fully Human Single-Domain Antibodies Targeting GUCY2C from a Heavy-Chain-Only Transgenic Mouse Platform. Technology in Cancer Research & Treatment. 2026;25. doi:10.1177/15330338261473054

BibTeX
@article{Zhu2026,
  author = {Zhu, Pingxia and He, Lei and Du, Xiaoming and Pang, Pengsha and Ji, Zhihua and Yang, Yanyu and Cao, Fengqi and Wang, Quanjun},
  title = {Isolation of Novel Fully Human Single-Domain Antibodies Targeting GUCY2C from a Heavy-Chain-Only Transgenic Mouse Platform},
  journal = {Technology in Cancer Research & Treatment},
  year = {2026},
  volume = {25},
  doi = {10.1177/15330338261473054}
}
Kostenlos starten →